Genetic parameters for ultrasound and carcass measures of yield and quality among replacement and slaughter beef cattle.

Real time ultrasound (RTU) measures of longissimus muscle area and fat depth were taken at 12 and 14 mo of age on composite bulls (n = 404) and heifers (n = 514). Carcass longissimus muscle area and fat depth, hot carcass weight, estimated percentage lean yield, marbling score, Warner-Bratzler shear force, and 7-rib dissectable seam fat and lean percentages were measured on steers (n = 235). Additive genetic variances for longissimus muscle area were 76 and 77% larger in bulls at 12 and 14 mo than the corresponding estimates for heifers. Heritability estimates for longissimus muscle area were 0.61 and 0.52 in bulls and 0.49 and 0.47 in heifers at 12 and 14 mo, respectively. The genetic correlations of longissimus muscle area of bulls vs heifers were 0.61 and 0.84 at 12 and 14 mo, respectively. Genetic correlations of longissimus muscle area measured in steer carcasses were 0.71 and 0.67 with the longissimus muscle areas in bulls and heifers at 12 mo and 0.73 and 0.79 at 14 mo. Heritability estimates for fat depth were 0.50 and 0.35 in bulls and 0.44 and 0.49 in heifers at 12 and 14 mo, respectively. The genetic correlation of fat depth in bulls vs heifers at 12 mo was 0.65 and was 0.49 at 14 mo. Genetic correlations of fat depth measured in bulls at 12 and 14 mo with fat depth measured in steers at slaughter were 0.23 and 0.21, and the corresponding correlations of between heifers and steers were 0.66 and 0.86, respectively. Live weights at 12 and 14 mo were genetically equivalent (r(g) = 0.98). Genetic correlations between live weights of bulls and heifers with hot carcass weight of the steers were also high (r(g) > 0.80). Longissimus muscle area measured using RTU was positively correlated with carcass measures of longissimus muscle area, estimated percentage lean yield, and percentage lean in a 7-rib section from steers. Measures of backfat obtained using RTU were positively correlated with fat depth and dissectable seam fat from the 7-rib section of steer carcasses. Genetic correlations between measures of backfat obtained using RTU and marbling were negative but low. These results indicate that longissimus muscle area and backfat may be under sufficiently different genetic control in bulls vs heifers to warrant being treated as separate traits in genetic evaluation models. Further, traits measured using RTU in potential replacement bulls and heifers at 12 and 14 mo of age may be considered different from the corresponding carcass traits of steers.     

Endogenous N-losses in piglets estimated by a [15N]-isotope dilution technique: effect of xylanase addition to a wheat and rye based diet.

The nitrogen pool of piglets weighing 19.4 +/- 1.4 kg at the beginning of the experiment was labeled with an oral application of ([15N]H4)2SO4 (1.26 [15N]-atom percent excess of dietary N) over a period of 7 d. The labeling period was followed by an equilibration period of 7 d without feeding the labeling compound. The two experimental diets were based on wheat (53%) and rye (25%) and were fed either with or without a xylanase containing enzyme preparation over both experimental periods. Additionally, diets were supplemented with an indigestible marker during the 2nd period of the experiment to allow the calculation of endogenous N-losses in subsequent segments of the digestive tract of the pigs. These endogenous N-losses were estimated at the end of the experiment by analyzing feces, ingesta and urine for [15N]-enrichment assuming that [15N]-enrichment of urine represents the [15N]-enrichment of the precursor pool. Endogenous N-losses were not significantly affected by xylanase addition at any measurement site (stomach, 3 sections of the small intestine, total digestive tract). Endogenous N-proportions of total nitrogen amounted on average for the six pigs to 42 +/- 11% and 56 +/- 5% at the last section of the small intestine and over the whole digestive tract, respectively, which corresponded to endogenous N-losses of 2.8 +/- 1.3 g N/kg DM and 2.0 +/- 0.3 g N/kg DM, respectively.     

Study on the performance enhancing effect of rare earth elements in growing and fattening pigs

A feeding study was performed to investigate possible performance enhancing effects of rare earth elements (REE) in growing and fattening pigs, as well as their influence on the blood serum biochemical changes and the accumulation of REE in the organs of pigs treated with a REE diet for a longer time period. Fourteen crossbred piglets (Deutsche Landrasse × Piétrain) were allotted to two dietary treatments: a control group and the REE-treated group which was supplemented with 300 mg of an REE mixture per kg feed. The REE mixture contained mainly chlorides of lanthanum (La), cerium (Ce) and praseodymium (Pr). The whole feeding period consisted of a 2 months ad libitum feeding period M-I and a 1 month restricted feeding period M-II. It was found that in comparison with the control group, the REE group had a better daily body weight gain of 19% (p   < 0.05) in the period M-I and 12% in the period M-II; the REE group also had a better feed conversion ratio of 11% in period M-I and 3% (p   > 0.05) in the period M-II. The REE had no significant (p   > 0.05) influence on blood serum thyroxine (T₄), aspartate-amino-transferase (AST), alanine-amino-transferase (ALT), alkaline-phosphatase (AP), total cholesterol, triglyceride, total protein, albumin, glucose, Ca, P, Na, K and Cl. However, serum triiodothyronine (T₃) in the REE group was significantly (p   < 0.01) lower than that in the control group. The accumulation rate of La and Ce in the muscle, liver and kidneys was very low after feeding the REE diet for 3 months. The study indicates the possibility of using rare earth elements as safe and inexpensive alternative performance enhancers for pig production.     

Treatment of methicillin-resistant Staphylococcus epidermidis infection following repair of an ulnar fracture and humeroradial joint luxation in a horse

A 27-month-old Rocky Mountain Horse was examined because of a fracture of the proximal portion of the ulna and luxation of the humeroradial joint (Monteggia fracture). Open reduction was performed, using a mechanical distractor, and the ulnar fracture was stabilized by application of a bone plate and screws. After surgery, the horse developed an infection of the surgical site, and bacterial culture of fluid from the surgical site yielded a pure growth of methicillin-resistant Staphylococcus epidermidis susceptible to oxytetracycline, erythromycin, rifampin, and vancomycin. Treatment with oxytetracycline did not result in a favorable clinical response. Therefore, the horse was treated systemically with vancomycin and rifampin, and vancomycin-impregnated polymethyl methacrylate beads were implanted at the surgical site. Six months after surgery, the horse was sound at a walk or trot, and bony union was evident on radiographs of the elbow joint.     

Influence of undegraded intake protein on reproductive performance of primiparous beef heifers maintained on stockpiled fescue pasture

The objectives of this study were to evaluate the effects of pre- and postpartum undegraded intake protein (UIP) supplementation on body condition score (BCS), BW, calf weight, milk production, serum IGF-I concentrations, and postpartum interval in primiparous beef heifers (n = 44). Heifers were maintained on endophyte-free stockpiled tall fescue (11.7% CP, 38% ADF) and individually fed supplement daily beginning 60 d prepartum. Pre- and postpartum supplements provided 19.3% CP, 83.4% TDN (UIP); 14.1% CP, 84.1% TDN (Control); 21.5% CP, 81.5% TDN (UIP); and 14.6% CP, 81.4% TDN (Control); respectively. Blood meal (146 g/d) was the source of UIP. Six heifers were removed from the study due to calf loss unrelated to treatment; therefore, postpartum measurements are based on 19 animals per treatment. Statistical analyses using ANOVA and a split-plot design revealed no effects of treatment (P > 0.2) on BCS, BW, calf weight, milk production, or postpartum interval. There tended to be a treatment x time interaction on BCS (P < 0.09) with UIP heifers having higher BCS than Control at wk 5, 7, and 9 postpartum. There was a treatment x time interaction on serum IGF-I (P < 0.06) during the first 35 d postpartum. In UIP heifers, serum IGF-I was greater at calving compared with Control heifers (117.5 vs 92.4 ng/mL, respectively); however, these differences were not related to changes in BCS or BW. Although serum IGF-I concentrations were increased at calving in heifers receiving UIP, there were no treatment effects on postpartum interval (P > 0.7). During the first 30 d postpartum, IGF-I differed (P < 0.01) among heifers with postpartum intervals defined as short, < 50 d (128.9 ng/mL); medium, 51 to 65 d (115.2 ng/mL); and long, 66 to 130 d (52.9 ng/mL). When analyzed as a regression, a 1 ng/mL increase in IGF-I (UIP and Control heifers) at calving (P < 0.05) and throughout the postpartum period (P < 0.01) corresponded to a decrease in postpartum interval of 0.13 d. Based on the results of this study, the inclusion of UIP in diets for primiparous heifers and its effects on postpartum interval warrant further evaluation.     

Clinical, biochemical, and molecular aspects of Glanzmann's thrombasthenia in humans and dogs

Glanzmann's thrombasthenia (GT) is an inherited, intrinsic platelet function defect that involves the platelet glycoprotein complex IIb-IIIa, also known as the fibrinogen receptor and the integrin alphaIIbbeta3. The defect was originally described by Dr. Glanzmann in humans in 1918 as a bleeding disorder that differed clinically from other known coagulopathies. Over the decades that followed, researchers determined the biochemical and molecular basis for the disease in humans. Otterhounds with thrombasthenic thrombopathia, described in the 1960s, were the only animal model that closely resembled the disease described in humans until 1996. At that time, a Great Pyrenees dog was identified with unequivocal clinical and biochemical features of Type I GT The cDNA encoding for glycoproteins IIb and IIIa were sequenced in normal dogs in 1999, allowing for identification of specific mutations causing Type I GT in both Otterhounds and Great Pyrenees dogs. Knowing the molecular basis for Type I GT in dogs as well as the cDNA sequences in normal dogs should enhance the understanding of structure/function relationships of the alphaIIbbeta3 integrin and provide an excellent animal model for studies aimed at correction of GT in humans. The following review focuses on the structure and function of this platelet receptor and reviews the molecular, biochemical, and clinical aspects of Glanzmann's thrombasthenia in humans and dogs.     

Evaluation of monoclonal antibodies for identification of subpopulations of myeloid cells in bone marrow obtained from dogs

OBJECTIVE: To evaluate monoclonal antibodies that may be useful for immunophenotyping myeloid cells in bone marrow of dogs. SAMPLE POPULATION: Bone marrow specimens obtained from 5 dogs. DESIGN: Specimens were labeled with monoclonal antibodies that detected CD18, major histocompatability antigen class-II (MHC class-II), CD14, and Thy-1. Cells labeled with each of the antibodies were isolated by use of a fluorescence-activated cell sorter. Differential cell counts of sorted cells were used to determine cells that were labeled by each of the various antibodies. RESULTS: Myeloid cells labeled with anti-CD18 antibody included granulocytes, lymphocytes, and monocytes-macrophages. Immature and mature granulocytes were labeled. Lymphocytes, monocytes-macrophages, and eosinophils were labeled with anti-Thy-1 antibody. Cells labeled with anti-MHC-class II antibody included approximately 9% of bone marrow cells, which consisted almost exclusively of lymphocytes and monocytes-macrophages. Approximately 4% of bone marrow cells were labeled with anti-CD14 antibody, with > 90% of sorted cells being monocytes-macrophages. CONCLUSIONS AND CLINICAL RELEVANCE: Four monoclonal antibodies for use in detecting subpopulations of canine bone marrow cells were evaluated. These antibodies should be useful in differentiating the origin of leukemic cells in dogs.